Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — February 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

EXELIXIS, INC. (EXEL)

Smith Julie — Director
Feb 18, 2026
Sale
Shares
44,087
Price
$44.50
Total Value
$1.96M
Shares Held After
20,590
% of Holdings
68.2%

Geron Corporation (GERN)

ROBERTSON MICHELLE — EVP, CHIEF FINANCIAL OFFICER
Feb 18, 2026
Sale
Shares
9,855
Price
$1.94
Total Value
$19.12K
Shares Held After
17,645
% of Holdings
35.8%
Feb 18, 2026
Sale
Shares
3,081
Price
$69.36
Total Value
$213.70K
Shares Held After
108,231
% of Holdings
2.8%

Gemini Therapeutics, Inc. (GMTX)

Franchi Jean M. — Chief Financial Officer
Feb 18, 2026
Sale
Shares
3,684
Price
$65.89
Total Value
$242.73K
Shares Held After
71,343
% of Holdings
4.9%

Gemini Therapeutics, Inc. (GMTX)

Franchi Jean M. — Chief Financial Officer
Feb 18, 2026
Sale
Shares
3,397
Price
$65.01
Total Value
$220.84K
Shares Held After
75,027
% of Holdings
4.3%
Feb 18, 2026
Sale
Shares
5,965
Price
$32.35
Total Value
$192.97K
Shares Held After
5,859
% of Holdings
50.4%

Immunocore Holdings plc (IMCR)

St Leger Tina Amber — CHIEF HR OFFICER
Feb 18, 2026
Sale
Shares
1,000
Price
$32.35
Total Value
$32.35K
Shares Held After
1,119
% of Holdings
47.2%

Immunocore Holdings plc (IMCR)

GOLL JOHN — SVP, FINANCE & CAO
Feb 18, 2026
Sale
Shares
698
Price
$32.35
Total Value
$22.58K
Shares Held After
653
% of Holdings
51.7%
Feb 18, 2026
Sale
Shares
11,474
Price
$32.35
Total Value
$371.18K
Shares Held After
12,343
% of Holdings
48.2%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Feb 18, 2026
Sale
Shares
368
Price
$473.68
Total Value
$174.31K
Shares Held After
48,650
% of Holdings
0.8%

Precision BioSciences, Inc. (DTIL)

SMITH J. JEFFERSON — Chief Research Officer
Feb 18, 2026
Sale
Shares
4,925
Price
$3.84
Total Value
$18.91K
Shares Held After
121,926
% of Holdings
3.9%
Feb 18, 2026
Sale
Shares
20,559
Price
$3.84
Total Value
$78.95K
Shares Held After
243,392
% of Holdings
7.8%

Precision BioSciences, Inc. (DTIL)

Scimeca Dario — General Counsel and Secretary
Feb 18, 2026
Sale
Shares
4,925
Price
$3.84
Total Value
$18.91K
Shares Held After
56,457
% of Holdings
8.0%

Precision BioSciences, Inc. (DTIL)

Kelly John Alexander — Chief Financial Officer
Feb 18, 2026
Sale
Shares
8,149
Price
$3.84
Total Value
$31.29K
Shares Held After
125,883
% of Holdings
6.1%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Ambrose Kristen — SVP & Chief Accounting Officer
Feb 18, 2026
Sale
Shares
638
Price
$473.68
Total Value
$302.21K
Shares Held After
7,750
% of Holdings
7.6%

Seer, Inc. (SEER)

Farokhzad Omid — Director
Feb 18, 2026
Sale
Shares
24,385
Price
$1.99
Total Value
$48.65K
Shares Held After
3,349,064
% of Holdings
0.7%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Feb 18, 2026
Sale
Shares
817
Price
$473.68
Total Value
$387.00K
Shares Held After
20,727
% of Holdings
3.8%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Biller Jonathan — EVP and Chief Legal Officer
Feb 18, 2026
Sale
Shares
1,244
Price
$473.68
Total Value
$589.26K
Shares Held After
15,748
% of Holdings
7.3%

Seer, Inc. (SEER)

Horn David R. — PRESIDENT & CFO
Feb 18, 2026
Sale
Shares
7,743
Price
$1.99
Total Value
$15.45K
Shares Held After
501,262
% of Holdings
1.5%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Bunnage Mark E. — EVP, Chief Scientific Officer
Feb 18, 2026
Sale
Shares
1,182
Price
$473.68
Total Value
$559.89K
Shares Held After
8,486
% of Holdings
12.2%

Ceribell, Inc. (CBLL)

Parvizi Josef — Director
Feb 18, 2026
Sale
Shares
6,986
Price
$20.00
Total Value
$139.72K
Shares Held After
739,366
% of Holdings
0.9%

APTARGROUP, INC. (ATR)

Touya Gael — Segment President
Feb 18, 2026
Sale
Shares
3,500
Price
$141.35
Total Value
$494.74K
Shares Held After
27,963
% of Holdings
11.1%
Feb 18, 2026
Purchase
Shares
3,000
Price
$3.02
Total Value
$9.06K
Shares Held After
18,000
% of Holdings
16.7%
Feb 18, 2026
Sale
Shares
16,644
Price
$5.82
Total Value
$96.92K
Shares Held After
235,405
% of Holdings
6.6%

JOHNSON & JOHNSON (JNJ)

Schmid Timothy — EVP, WW Chair, MedTech
Feb 18, 2026
Sale
Shares
8,998
Price
$244.53
Total Value
$2.20M
Shares Held After
26,769
% of Holdings
25.2%

JOHNSON & JOHNSON (JNJ)

Schmid Timothy — EVP, WW Chair, MedTech
Feb 18, 2026
Sale
Shares
13,625
Price
$244.20
Total Value
$3.33M
Shares Held After
26,769
% of Holdings
33.7%

Solid Biosciences Inc. (SLDB)

Brooks Gabriel — Chief Medical Officer
Feb 18, 2026
Sale
Shares
0
Price
$5.82
Total Value
$0.00
Shares Held After
89,466
% of Holdings
0.0%

Solid Biosciences Inc. (SLDB)

Tan Kevin — CFO & Treasurer
Feb 18, 2026
Sale
Shares
5,404
Price
$5.82
Total Value
$31.47K
Shares Held After
99,422
% of Holdings
5.2%

Solid Biosciences Inc. (SLDB)

Howton David T — Chief Operating Officer
Feb 18, 2026
Sale
Shares
7,469
Price
$5.82
Total Value
$43.49K
Shares Held After
105,077
% of Holdings
6.6%
Feb 18, 2026
Sale
Shares
2,658
Price
$5.82
Total Value
$15.48K
Shares Held After
27,474
% of Holdings
8.8%

Solid Biosciences Inc. (SLDB)

Herzich Paul — Chief Technology Officer
Feb 18, 2026
Sale
Shares
3,616
Price
$5.82
Total Value
$21.06K
Shares Held After
72,638
% of Holdings
4.7%

Solid Biosciences Inc. (SLDB)

Hanrahan Jessie — Chief Regulatory Officer
Feb 18, 2026
Sale
Shares
4,134
Price
$5.82
Total Value
$24.07K
Shares Held After
74,318
% of Holdings
5.3%

Adagio Therapeutics, Inc. (ADGI)

Andersen Jill — Chief Legal Officer, Secretary
Feb 18, 2026
Sale
Shares
34,939
Price
$1.58
Total Value
$55.13K
Shares Held After
181,736
% of Holdings
16.1%

Adagio Therapeutics, Inc. (ADGI)

Lee Timothy Edward — Chief Commercial Officer
Feb 18, 2026
Sale
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
117,717
% of Holdings
15.1%

EXELIXIS, INC. (EXEL)

Hefti Brenda — SVP and General Counsel
Feb 18, 2026
Sale
Shares
18,669
Price
$44.01
Total Value
$821.62K
Shares Held After
96,512
% of Holdings
16.2%

Adagio Therapeutics, Inc. (ADGI)

Duke William E. — Chief Financial Officer
Feb 18, 2026
Sale
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
107,717
% of Holdings
16.3%

Adagio Therapeutics, Inc. (ADGI)

Green Julie — Chief Human Resources Officer
Feb 18, 2026
Sale
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
107,717
% of Holdings
16.3%

Adagio Therapeutics, Inc. (ADGI)

Allen Robert D. III — Chief Scientific Officer
Feb 18, 2026
Sale
Shares
19,392
Price
$1.58
Total Value
$30.60K
Shares Held After
114,487
% of Holdings
14.5%
Feb 18, 2026
Sale
Shares
216
Price
$51.97
Total Value
$11.23K
Shares Held After
36,680
% of Holdings
0.6%
Feb 18, 2026
Sale
Shares
6,824
Price
$51.38
Total Value
$350.60K
Shares Held After
36,896
% of Holdings
15.6%
Feb 18, 2026
Sale
Shares
9,673
Price
$1.71
Total Value
$16.54K
Shares Held After
392,700
% of Holdings
2.4%

HCA Healthcare, Inc. (HCA)

McAlevey Michael R — EVP & Chief Legal & Admin Off.
Feb 18, 2026
Sale
Shares
1,694
Price
$533.37
Total Value
$903.54K
Shares Held After
8,853
% of Holdings
16.1%
Feb 18, 2026
Sale
Shares
30,843
Price
$1.71
Total Value
$52.74K
Shares Held After
4,403,277
% of Holdings
0.7%

Avista Public Acquisition Corp. II (AHPA)

GUSTAFSON KURT A — Executive VP, Finance and CFO
Feb 18, 2026
Sale
Shares
9,301
Price
$1.71
Total Value
$15.90K
Shares Held After
268,851
% of Holdings
3.3%
Feb 18, 2026
Sale
Shares
953
Price
$182.61
Total Value
$174.03K
Shares Held After
36,763
% of Holdings
2.5%

CVRx, Inc. (CVRX)

Jain Mudit K. — Director
Feb 18, 2026
Purchase
Shares
600
Price
$4.64
Total Value
$2.79K
Shares Held After
5,650
% of Holdings
10.6%
Feb 18, 2026
Purchase
Shares
133,688
Price
$1.32
Total Value
$176.47K
Shares Held After
1,654,186
% of Holdings
8.1%

ILLUMINA, INC. (ILMN)

Leckman Patricia — SVP, Chief People Officer
Feb 18, 2026
Sale
Shares
2,370
Price
$116.18
Total Value
$275.35K
Shares Held After
16,321
% of Holdings
12.7%

Cardinal Health, Inc. (CAH)

Alt Aaron E — Chief Financial Officer
Feb 18, 2026
Sale
Shares
2,328
Price
$225.50
Total Value
$524.96K
Shares Held After
26,408
% of Holdings
8.1%

Dermata Therapeutics, Inc. (DRMA)

Bedoya-Toro Munera Maria E — SVP, Regulatory Affairs
Feb 17, 2026
Purchase
Shares
1,000
Price
$1.27
Total Value
$1.27K
Shares Held After
1,012
% of Holdings
98.8%
Version: v26.3.28